Metzger DW - Search Results

1

Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.

Ulery BD, Petersen LK, Phanse Y, Kong CS, Broderick SR, Kumar D, Ramer-Tait AE, Carrillo-Conde B, Rajan K, Wannemuehler MJ, Bellaire BH, Metzger DW, Narasimhan B. Ulery BD, et al. Among authors: metzger dw. Sci Rep. 2011;1:198. doi: 10.1038/srep00198. Epub 2011 Dec 16. Sci Rep. 2011. PMID: 22355713 Free PMC article.

2

Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases.

Ulery BD, Kumar D, Ramer-Tait AE, Metzger DW, Wannemuehler MJ, Narasimhan B. Ulery BD, et al. Among authors: metzger dw. PLoS One. 2011 Mar 3;6(3):e17642. doi: 10.1371/journal.pone.0017642. PLoS One. 2011. PMID: 21408610 Free PMC article.

3

Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague.

Kumar D, Kirimanjeswara G, Metzger DW. Kumar D, et al. Among authors: metzger dw. Clin Vaccine Immunol. 2011 Nov;18(11):1925-35. doi: 10.1128/CVI.05117-11. Epub 2011 Aug 31. Clin Vaccine Immunol. 2011. PMID: 21880856 Free PMC article.

4

Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.

Hazlett KR, Caldon SD, McArthur DG, Cirillo KA, Kirimanjeswara GS, Magguilli ML, Malik M, Shah A, Broderick S, Golovliov I, Metzger DW, Rajan K, Sellati TJ, Loegering DJ. Hazlett KR, et al. Among authors: metzger dw. Infect Immun. 2008 Oct;76(10):4479-88. doi: 10.1128/IAI.00610-08. Epub 2008 Jul 21. Infect Immun. 2008. PMID: 18644878 Free PMC article.

5

Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.

Sabirov A, Metzger DW. Sabirov A, et al. Among authors: metzger dw. Vaccine. 2006 Jul 7;24(27-28):5584-92. doi: 10.1016/j.vaccine.2006.04.033. Epub 2006 May 8. Vaccine. 2006. PMID: 16730398

6

Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue.

Sabirov A, Metzger DW. Sabirov A, et al. Among authors: metzger dw. Vaccine. 2008 Mar 17;26(12):1566-76. doi: 10.1016/j.vaccine.2008.01.027. Epub 2008 Feb 4. Vaccine. 2008. PMID: 18281130 Free PMC article.

7

Interleukin-12 as an adjuvant for induction of protective antibody responses.

Metzger DW. Metzger DW. Cytokine. 2010 Oct-Nov;52(1-2):102-7. doi: 10.1016/j.cyto.2010.06.011. Epub 2010 Jul 22. Cytokine. 2010. PMID: 20650650 Free PMC article. Review.

8

A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection.

Sun K, Torres L, Metzger DW. Sun K, et al. Among authors: metzger dw. J Virol. 2010 May;84(10):5007-14. doi: 10.1128/JVI.02408-09. Epub 2010 Mar 3. J Virol. 2010. PMID: 20200252 Free PMC article.

9

Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity.

Arulanandam BP, O'Toole M, Metzger DW. Arulanandam BP, et al. Among authors: metzger dw. J Infect Dis. 1999 Oct;180(4):940-9. doi: 10.1086/314996. J Infect Dis. 1999. PMID: 10479116

10

Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery.

Arulanandam BP, Metzger DW. Arulanandam BP, et al. Among authors: metzger dw. Vaccine. 1999 Jan 21;17(3):252-60. doi: 10.1016/s0264-410x(98)00157-1. Vaccine. 1999. PMID: 9987161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page